Rua Bioscience Limited (NZE:RUA)

Rua Bioscience Balance Sheet

Financials in millions NZD. Fiscal year is July - June.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	2.17	0.24	0.9	2.53	1.9	3.36
Short-Term Investments	-	-	-	2.03	8.04	13.04
Cash & Short-Term Investments	2.17	0.24	0.9	4.56	9.94	16.4
Cash Growth	797.31%	-73.03%	-80.38%	-54.11%	-39.40%	316.53%
Accounts Receivable	0.37	0.21	0.03	0.1	-	-
Other Receivables	-	0.15	0.24	0.68	0.54	0.6
Receivables	0.37	0.37	0.26	0.78	0.54	0.6
Inventory	0.68	0.75	0.61	0.12	0.22	-
Prepaid Expenses	0.35	0.06	0.15	0.06	0.17	0.11
Restricted Cash	-	-	-	-	0.5	-
Other Current Assets	0.88	0.89	0.89	0.09	0.03	0
Total Current Assets	4.45	2.31	2.82	5.6	11.39	17.12
Property, Plant & Equipment	1.98	2.21	2.65	4.54	6.64	7.1
Goodwill	2.19	2.19	2.19	10.45	10.45	4
Other Intangible Assets	-	-	-	0.29	5.02	-
Long-Term Deferred Tax Assets	-	-	-	-	-	2.55
Other Long-Term Assets	0.08	0.08	0.08	0.08	0.08	0.08
Total Assets	8.7	6.78	7.74	20.95	33.57	30.85

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Accounts Payable	0.87	0.69	0.42	0.28	0.32	0.45
Accrued Expenses	0.13	0.32	0.31	0.24	0.46	0.52
Short-Term Debt	1.77	0.73	-	-	-	-
Current Portion of Long-Term Debt	-	-	-	-	-	0.01
Current Portion of Leases	0.01	0.04	0.05	0.05	0.13	0.13
Current Unearned Revenue	0.03	-	0.07	0.01	0.01	-
Other Current Liabilities	0.02	0.08	0.03	0.18	3.94	0.06
Total Current Liabilities	2.83	1.85	0.87	0.76	4.86	1.18
Long-Term Leases	0.03	0.04	0.1	0.07	0.7	0.81
Other Long-Term Liabilities	-	-	-	-	3.82	0.03
Total Liabilities	2.86	1.89	0.97	0.83	9.38	2.02

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Common Stock	48.17	45.45	43.95	43.7	41.89	37.42
Retained Earnings	-42.76	-40.97	-37.51	-23.79	-17.84	-9.2
Comprehensive Income & Other	0.44	0.41	0.33	0.21	0.14	0.61
Shareholders' Equity	5.84	4.89	6.77	20.12	24.2	28.83
Total Liabilities & Equity	8.7	6.78	7.74	20.95	33.57	30.85

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Total Debt	1.81	0.8	0.15	0.11	0.82	0.95
Net Cash (Debt)	0.35	-0.56	0.75	4.45	9.11	15.45
Net Cash Growth	-	-	-83.19%	-51.21%	-40.99%	330.41%
Net Cash Per Share	0.00	-0.00	0.00	0.03	0.06	0.12
Filing Date Shares Outstanding	338.04	223.65	159.75	158.14	149.88	140.26
Total Common Shares Outstanding	338.04	223.65	159.75	158.14	149.88	140.26
Working Capital	1.63	0.45	1.94	4.84	6.54	15.94
Book Value Per Share	0.02	0.02	0.04	0.13	0.16	0.21
Tangible Book Value	3.65	2.7	4.57	9.39	8.73	24.83
Tangible Book Value Per Share	0.01	0.01	0.03	0.06	0.06	0.18
Buildings	-	2.94	2.96	4.34	4.82	4.72
Machinery	-	1.28	1.58	1.85	2.27	1.88

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error